𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognostic variables in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy

✍ Scribed by Fountzilas, George; Gossios, Konstantinos; Zisiadis, Alkis; Svarna, Eugenia; Skarlos, Dimosthenis; Pavlidis, Nicholas


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
796 KB
Volume
26
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Possible prognostic variables for tumor response, time to progression (XP), and survival in 141 patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy were analyzed, None of the variables examined for their possible influence on tumor response attained significance in the stepwise logistic regression. In the univariate analysis, variables found to be strongly associated with l T P were performance status (PS) (P = 0.0301), liver involvement (P = 0.030), and the initial values of WBC ( P = 0.0319), lactic dehydrogenase (LDH; P = 0.0053), y-glutamyl-transpeptidase (yCT; P = 0.0013), alkaline phosphatase (ALP; P = 0.0186), albumin (P = 0.0004), and carcinoembryonic antigen (CEA; P =0.0014). In the Cox analysis, liver involvement (P = 0.0553), albumin ( P = 0.0181), PS (P =0.0484),and ALP ( P = 0.0553) were retained as independently significant variables. When only patients with liver metastases were included in the analysis, then only albumin (P < 0.001) demonstrated a prognostic significance. Also, in the univariate analysis, variables predicting survival were PS (P = 0.0230), grade (P = 0.0060), liver involvement (P = ALP (P = 0.0006), albumin (P = 0.0309), and CEA (P = O.OOOS).With the multivariate analysis, y-CT (P = 0.0004), albumin ( P = 0.0634), and CEA (P = 0.0804) were selected as significant. In those patients who presented with liver involvement, variables predicted survival werey-GT (P = 0.0041), albumin (P = O.O442), and the percentage of involved liver parenchyma (P = 0.0690). These results could be helpful for the stratification of future trials in advanced colorectal cancer.


πŸ“œ SIMILAR VOLUMES


Hypocalcemia associated with 5-fluoroura
✍ Yuichiro Kido; Takeshi Okamura; Morimasa Tomikawa; Manabu Yamamoto; Morio Shirai πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 367 KB πŸ‘ 2 views

## BACKGROUND. The biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (Lv) has demonstrated significantly increased response rates in comparison with the use of 5-FU alone in patients with advanced colorectal carcinoma. However, the higher response rate of LV/5-FU may occur at the expen